Lutein protects retinal pigment epithelium from cytotoxic oxidative stress

Ravi K. Murthy,Kavitha Ravi,Sankarathi Balaiya,Vikram S. Brar,Kakarla V. Chalam

DOI: https://doi.org/10.3109/15569527.2013.812108

2013-07-18

Cutaneous and Ocular Toxicology

Abstract:CONTEXT: Lutein (LUT) and zeaxanthin (ZEA) are currently under investigation in clinical trials as prophylactic nutritional agents for age-related macular degeneration (AMD). However, dose used in these trials is empirical and not been investigated in in vitro studies.OBJECTIVE: In this study, we investigated the dose-response effect of LUT and ZEA in protecting retinal pigment epithelium (RPE) from oxidative stress, a common underlying pathology in AMD.METHODS: Three thousand cultured human retinal pigment epithelial cells (ARPE-19) were plated in 72-well plate and after 24 h were exposed to increasing concentrations of hydrogen peroxide (H2O2). ARPE-19 cells were exposed to four different concentrations of LUT (0.5, 1, 2 and 4 µg/mL) and ZEA (0.1, 0.2, 0.4 and 0.8 µg/mL). After 24 h incubation, cells were subjected to oxidative stress induced with H2O2. Cultures containing saline solution and dichloromethane served as controls. Cell viability was assessed using the WST-1 assay. Pathophysiological pathways were evaluated by measuring caspase-3 levels as an indicator of apoptosis induction. Reactive oxygen species (ROS) levels were measured using dihydrorhodamine-123.RESULTS: Cell viability as a percentage of control was 81.3%, 81.1%, and 88.8% at 0.5, 1, and 2 µg/ml, respectively of LUT (p < 0.001). The maximum cytoprotective effect was seen with LUT at 2 μg/mL. ZEA did not show any cytoprotective effect at all concentrations used in the study. Caspase-3 showed a corresponding decrease in levels with LUT (1 and 2 µg/ml). Significant decrease in ROS levels were measured only with LUT at 4 µg/ml (p = 0.02).DISCUSSION AND CONCLUSIONS: Results from our study provide in vitro data to support the epidemiologic studies, which are currently underway to provide evidence that lutein may act as cofactor that modulates processes implicated in AMD pathogenesis.

ophthalmology,toxicology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the protective effects of lutein (LUT) and zeaxanthin (ZEA) at different doses on retinal pigment epithelial cells (RPE) against oxidative stress. Specifically, the study aims to:

1. **Evaluate the dose - response relationship of lutein and zeaxanthin**: Study the protective effects of different concentrations of lutein and zeaxanthin on RPE cells to determine their optimal antioxidant doses.
2. **Verify the antioxidant mechanism**: Evaluate the antioxidant effects of these two carotenoids at the cellular level by measuring cell viability, caspase - 3 levels, and reactive oxygen species (ROS) levels.

### Research Background
Age - related macular degeneration (AMD) is one of the leading causes of blindness in Western countries. Oxidative stress is considered one of the important pathological mechanisms in the progression of AMD. Retinal pigment epithelial cells (RPE) play a crucial role in AMD because they are vulnerable to light - induced oxidative stress, which in turn leads to cell damage and death.

### Research Methods
The researchers used the ARPE - 19 cell line (a human RPE cell line) and carried out the following experiments:
- **Oxidative stress treatment**: Treat cells with different concentrations of hydrogen peroxide (H₂O₂) to simulate in - vivo oxidative stress conditions.
- **Drug pretreatment**: Pretreat cells with different concentrations of lutein (0.5, 1, 2, and 4 mg/mL) and zeaxanthin (0.1, 0.2, 0.4, and 0.8 mg/mL) before oxidative stress.
- **Cell viability assay**: Use the WST - 1 method to assess cell viability.
- **Caspase - 3 level assay**: As an apoptosis indicator, use the ELISA method to measure caspase - 3 levels.
- **ROS level assay**: Use the fluorescent probe DHR - 123 to measure ROS levels.

### Main Results
- **Protective effect of lutein**: Lutein showed significant cell - protective effects at 0.5, 1, and 2 mg/mL, with the best effect at 2 mg/mL. However, at 4 mg/mL, lutein instead exhibited cytotoxicity.
- **Effect of zeaxanthin**: Zeaxanthin did not show significant cell - protective effects at all tested concentrations and exhibited cytotoxicity at higher concentrations (0.4 and 0.8 mg/mL).
- **ROS levels**: Lutein significantly reduced ROS levels at 4 mg/mL, while no obvious effect was observed at lower concentrations. Zeaxanthin did not significantly reduce ROS levels at all concentrations.

### Conclusion
This study provides in - vitro data to support epidemiological studies, indicating that lutein may play a protective role by regulating the pathological processes related to AMD. However, zeaxanthin did not show a similar protective effect and even exhibited cytotoxicity at high concentrations. These findings suggest that when using these carotenoids in supplements, the dose should be carefully selected to avoid potential adverse effects.

### Formula Summary
- Cell viability assay formula:
\[
\text{Cell Viability (\%)} = \left( \frac{\text{Absorbance of treated cells}}{\text{Absorbance of control cells}} \right) \times 100
\]
- ROS level change formula:
\[
\Delta \text{ROS} = \left( \frac{\text{Absorbance of treated cells} - \text{Absorbance of control cells}}{\text{Absorbance of control cells}} \right) \times 100
\]

These results provide an important reference for ongoing clinical trials and help optimize the dosage of carotenoids.